These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25505026)

  • 1. The need for transparency and efficiency in reimbursement decisions relating to drugs for rare diseases.
    Coyle DA; Cheung MC; Evans GA
    Med Decis Making; 2015 Feb; 35(2):145-7. PubMed ID: 25505026
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of transparency in assessing the feasibility of modeling rare disease.
    Johnson SJ; Davis MR; Wang ST
    Med Decis Making; 2015 Feb; 35(2):143-4. PubMed ID: 25505051
    [No Abstract]   [Full Text] [Related]  

  • 3. Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuria.
    Coyle D; Cheung MC; Evans GA
    Med Decis Making; 2014 Nov; 34(8):1016-29. PubMed ID: 24990825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare diseases mean big profits.
    Murphy RM
    Fortune; 2012 Sep; 166(4):24. PubMed ID: 23072062
    [No Abstract]   [Full Text] [Related]  

  • 5. Applying complement therapeutics to rare diseases.
    Reis ES; Mastellos DC; Yancopoulou D; Risitano AM; Ricklin D; Lambris JD
    Clin Immunol; 2015 Dec; 161(2):225-40. PubMed ID: 26341313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eculizumab in paroxysmal nocturnal hemoglobinuria].
    Birgens H
    Ugeskr Laeger; 2011 Mar; 173(10):714. PubMed ID: 21375975
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxysmal nocturnal hemoglobinuria in the era of complement inhibition.
    Risitano AM
    Am J Hematol; 2016 Jun; 91(4):359-60. PubMed ID: 26852134
    [No Abstract]   [Full Text] [Related]  

  • 8. Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):79-80. PubMed ID: 17878890
    [No Abstract]   [Full Text] [Related]  

  • 9. Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Iki S; Ohgi K; Suzuki K
    Int J Hematol; 2017 Mar; 105(3):231-232. PubMed ID: 27873177
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the management of paroxysmal nocturnal hemoglobinuria by eculizumab].
    Nakakuma H
    Rinsho Ketsueki; 2011 Aug; 52(8):633-44. PubMed ID: 21897069
    [No Abstract]   [Full Text] [Related]  

  • 11. Update in paroxysmal nocturnal hemoglobinuria.
    Hillmen P
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):391-3. PubMed ID: 22895241
    [No Abstract]   [Full Text] [Related]  

  • 12. Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria.
    Tomita A; Shirasugi Y; Ito T; Tsurumi H; Naoe T
    Ann Hematol; 2012 Jul; 91(7):1139-41. PubMed ID: 22080148
    [No Abstract]   [Full Text] [Related]  

  • 13. Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria.
    Keating GM; Lyseng-Williamson KA; McKeage K
    BioDrugs; 2012 Apr; 26(2):125-30. PubMed ID: 22350448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel therapeutics for paroxysmal nocturnal hemoglobinuria].
    Nishimura J
    Rinsho Ketsueki; 2011 Oct; 52(10):1515-24. PubMed ID: 21971228
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of eculizumab against Eosinophilic Fasciitis associated with Paroxysmal Nocturnal Haemoglobinuria.
    Frumholtz L; Sebert M; de Masson A; Attias P; Ades L; Roux J; Jachiet M; Cabannes-Hamy A; Elena Noguera M; Attencourt C; Bagot M; Socié G; Rybojad M; de La Tour RP; Bouaziz JD
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e101-e102. PubMed ID: 27401544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].
    Taniguchi A; Ikezoe T; Takeuchi A; Togitani K; Yoshimoto M; Tanioka K; Kitaoka H; Yokoyama A
    Rinsho Ketsueki; 2014 Aug; 55(8):965-9. PubMed ID: 25186487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report].
    Horányi D; Várkonyi A; Nagy GR; Bodó I; Masszi T
    Orv Hetil; 2016 Jun; 157(23):916-8; quiz 919-20. PubMed ID: 27233835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Muus P; Szer J; Hill A; Höchsmann B; Kulasekararaj A; Risitano AM; Van Den Neste E; Liljeholm M; Ebrahim KS; Bedrosian CL; Gao X; Ames D; Socié G
    Am J Hematol; 2016 Mar; 91(3):E16-7. PubMed ID: 26690023
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaesthesia and orphan disease: laparoscopic cholecystectomy with paroxysmal nocturnal haemoglobinuria and human mAb therapy.
    Vargas M; Lallo C; Marra A; Servillo G
    Eur J Anaesthesiol; 2013 Dec; 30(12):770-2. PubMed ID: 23756354
    [No Abstract]   [Full Text] [Related]  

  • 20. [C5: eculizumab].
    Miyamoto K
    Brain Nerve; 2014 Oct; 66(10):1191-9. PubMed ID: 25296873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.